The genetic backbone modulates the phenotype of Hepatitis B surface antigen mutants

Journal of General Virology

Volumn 91, Issue 1, 2010, Pages 68-73

  Beale, Mathew A ^a   Ijaz, Samreen ^a   Tedder, Richard S ^a  

^a Centre for Infections   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DNA POLYMERASE; EPITOPE; HEPATITIS B SURFACE ANTIGEN; MONOCLONAL ANTIBODY; MUTANT PROTEIN; VIRUS DNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DNA CONFORMATION; DNA SEQUENCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; GENETIC REGULATION; GENOTYPE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; VIRAL GENETICS; VIRUS RESISTANCE;

ANTIBODIES, MONOCLONAL; DNA, VIRAL; DRUG RESISTANCE, VIRAL; EPITOPES; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; MOLECULAR SEQUENCE DATA; MUTATION, MISSENSE; SEQUENCE ANALYSIS, DNA;

HEPATITIS B VIRUS;

EID: 73149090983     PISSN: 00221317     EISSN: 14652099     Source Type: Journal    
DOI: 10.1099/vir.0.013078-0     Document Type: Article

References (23)

1. Carman, W. F., Zanetti, A. R., Karayiannis, P., Waters, J., Manzillo, G., Tanzi, E., Zuckerman, A. J. & Thomas, H. C. (1990). Vaccine-induced escape mutant of hepatitis B virus. Lancet 336, 325-329.
2. Chen, Y. C., Delbrook, K., Dealwis, C., Mimms, L., Mushahwar, I. K. & Mandecki, W. (1996). Discontinuous epitopes of hepatitis B surface antigen derived from a filamentous phage peptide library. Proc Natl Acad Sci U S A 93, 1997-2001.
3. Cooreman, M. P., Leroux-Roels, G. & Paulij, W. P. (2001). Vaccine-and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 8, 237-247.
4. Datta, S., Banerjee, A., Chandra, P. K., Chowdhury, A. & Chakravarty, R. (2006). Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers. J Med Virol 78, 53-59.
5. Hadziyannis, S. J., Tassopoulos, N. C., Heathcote, E. J., Chang, T., Kitis, G., Rizzetto, M., Marcellin, P., Lim, S. G., Goodman, Z. & other authors (2005). Long-term therapy with adefovir dipivoxil for HBeAg-negative chronic hepatitis B. N Engl J Med 352, 2673-2681.
6. Hou, J., Wang, Z., Cheng, J., Lin, Y., Lau, G. K., Sun, J., Zhou, F., Waters, J., Karayiannis, P. & Luo, K. (2001). Prevalence of naturally occurring surface gene variants of hepatitis B virus in nonimmunized surface antigen-negative Chinese carriers. Hepatology 34, 1027-1034.
7. Hsu, H.-Y., Chang, M.-H., Ni, Y.-H. & Chen, H.-L. (2004). Survey of hepatitis B surface variant infection in children 15 years after a nationwide vaccination programme in Taiwan. Gut 53, 1499-1503.
8. Ijaz, S., Ferns, R. B. & Tedder, R. S. (2003). A 'first loop' linear epitope accessible on native hepatitis B surface antigen that persists in the face of 'second loop' immune escape. J Gen Virol 84, 269-275.
9. Ijaz, S., Arnold, C., Dervisevic, S., Mechurova, J., Tatman, N., Tedder, R. S. & Naoumov, N. V. (2008). Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy. J Med Virol 80, 1160-1170.
10. Norder, H., Couroucé, A., Coursaget, P., Echevarria, J. M., Lee, S., Mushahwar, I. K., Robertson, B. H., Locarnini, S. & Magnius, L. O. (2004). Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 47, 289-309.
11. Osiowy, C., Villeneuve, J., Heathcote, E. J., Giles, E. & Borlang, J. (2006). Detection of rtN236T and rtA181V/T mutations associated with resistance to adefovir dipivoxil in samples from patients with chronic hepatitis B virus infection by the INNO-LiPA HBV DR line probe assay (version 2). J Clin Microbiol 44, 1994-1997.
12. Paulij, W. P., de Wit, P. L., Sünnen, C. M., van Roosmalen, M. H., Petersen-van Ettekoven, A., Cooreman, M. P. & Heijtink, R. A. (1999). Localization of a unique hepatitis B virus epitope sheds new light on the structure of hepatitis B virus surface antigen. J Gen Virol 80, 2121-2126.
13. Protzer-Knolle, U., Naumann, U., Bartenschlager, R., Berg, T.,Hopf, U., Meyer zum Büschenfelde, K. H., Neuhaus, P. & Gerken, G. (1998). Hepatitis B virus with antigenically altered hepatitis B surface antigen is selected by high-dose hepatitis B immune globulin after liver transplantation. Hepatology 27, 254-263.
14. Salisse, J. & Sureau, C. (2009). A function essential to viral entry underlies the hepatitis B virus "a" determinant. J Virol 83, 9321-9328.
15. Seeger, C., Zoulim, F. & Mason, W. S. (2007). Hepadnaviruses. Fields Virology, 5th edn, pp. 2977-3029. Edited by D. M. Knipe & P. M. Howley. Philadelphia: Lippincott Williams & Wilkins.
16. Sloan, R. D., Ijaz, S., Moore, P. L., Harrison, T. J., Teo, C. & Tedder, R. S. (2008). Antiviral resistance mutations potentiate hepatitis B virus immune evasion through disruption of its surface antigen a determinant. Antivir Ther 13, 439-447.
17. Stirk, H. J., Thornton, J. M. & Howard, C. R. (1992). A topological model for hepatitis B surface antigen. Intervirology 33, 148-158.
18. Tedder, R. S., Guarascio, P., Yao, J. L., Lord, R. B. & Eddleston, A. L. (1983). Production of monoclonal antibodies to hepatitis B surface and core antigens, and use in the detection of viral antigens in liver biopsies. J Hyg (Lond) 90, 135-142.
19. Torresi, J., Earnest-Silveira, L., Civitico, G., Walters, T. E., Lewin, S. R., Fyfe, J., Locarnini, S. A., Manns, M., Trautwein, C. & Bock, T. C. (2002a). Restoration of replication phenotype of lamivudine-resistant hepatitis B virus mutants by compensatory changes in the "fingers" subdomain of the viral polymerase selected as a consequence of mutations in the overlapping S gene. Virology 299, 88-99.
20. Torresi, J., Earnest-Silveira, L., Deliyannis, G., Edgtton, K., Zhuang, H., Locarnini, S. A., Fyfe, J., Sozzi, T. & Jackson, D. C. (2002b). Reduced antigenicity of the hepatitis B virus HBsAg protein arising as a consequence of sequence changes in the overlapping polymerase gene that are selected by lamivudine therapy. Virology 293, 305-313.
21. van Hemert, F. J., Zaaijer, H. L., Berkhout, B. & Lukashov, V. V. (2008). Mosaic amino acid conservation in 3D-structures of surface protein and polymerase of hepatitis B virus. Virology 370, 362-372.
22. Warner, N. & Locarnini, S. (2008). The antiviral drug selected hepatitis B virus rtA181T/sW172* mutant has a dominant negative secretion defect and alters the typical profile of viral rebound. Hepatology 48, 88-98.
23. Ziermann, R. & Ganem, D. (1996). Homologous and heterologous complementation of HBV and WHV capsid and polymerase functions in RNA encapsidation. Virology 219, 350-356.